Sugi Predict

Sugi Predict / Compounds / SCHEMBL5653071

SCHEMBL5653071

SCHEMBL5653071

CCOC(=O)c1sc2c(ccc(=O)n2-c2ccc(N3CCN(C)CC3)cc2)c1-c1ccc(F)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 2/20 0.41
▸ BTK Q06187 2/20 0.40
▸ LMNA P02545 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ THRB P10828 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ TDO2 P48775 1/20 0.37
▸ IDO2 Q6ZQW0 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5653006 0.99 TRPV4 (0.40) TRPV4BTKLMNASMN1; SMN2KDM4E
SCHEMBL5653909 0.87 ALDH1A1 (0.39) SMN1; SMN2KDM4EMAPTHSD17B10ALDH1A1
SCHEMBL5651315 0.87 MAPT (0.43) SMN1; SMN2KDM4EMAPTHSD17B10ALDH1A1
SCHEMBL5649662 0.80 MAPT (0.43) SMN1; SMN2KDM4EMAPTHSD17B10ALDH1A1
SCHEMBL5654208 0.78 MAPT (0.47) LMNASMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL5647895 0.76 MAPT (0.41) LMNASMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL5652293 0.76 MAPT (0.44) LMNASMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL5648220 0.74 IDO1 (0.41) TRPV4LMNASMN1; SMN2MAPTIDO1
SCHEMBL5653711 0.74 LMNA (0.48) LMNASMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL5652325 0.74 MAPT (0.47) LMNASMN1; SMN2KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176215-B2 Bicyclic oxopyridine and oxopyrimidine derivatives CELLTECH R&D LIMITED (GB) 2007-02-13 — — US claimed
US-20050059681-A1 Far field light microscopical method system and computer program product for analysing at least one object having a subwavelength size RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) 2005-03-17 — — US claimed
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives UCB PHARMA S.A. (BE) 2004-12-16 — — US claimed
US-7176215-B2 Bicyclic oxopyridine and oxopyrimidine derivatives CELLTECH R&D LIMITED (GB) 2007-02-13 — — US disclosed
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives UCB PHARMA S.A. (BE) 2004-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059681-A1 Far field light microscopical method system and computer program product for analysing at least one object having a subwavelength size CFL1, INF2, COG6 TRPV4 2354/4885BTK 1831/4885LMNA 2270/4885
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives MAPK1, ALK, NAT1 TRPV4 3914/4885BTK 285/4885LMNA 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.